Edition:
United States

Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

13.85USD
25 Jun 2018
Change (% chg)

$-0.20 (-1.42%)
Prev Close
$14.05
Open
$14.05
Day's High
$14.10
Day's Low
$13.85
Volume
9,567
Avg. Vol
119,885
52-wk High
$30.35
52-wk Low
$13.20

Chart for

About

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June... (more)

Overall

Beta: 2.50
Market Cap(Mil.): $534.10
Shares Outstanding(Mil.): 38.01
Dividend: --
Yield (%): --

Financials

  LCI.N Industry Sector
P/E (TTM): 8.29 29.56 34.14
EPS (TTM): 1.69 -- --
ROI: 4.59 13.56 13.10
ROE: 11.11 15.35 15.09

BRIEF-Lannett Receives FDA Approval For Dronabinol Capsules

* LANNETT COMPANY INC - RECEIVED APPROVAL OF ABBREVIATED NEW DRUG APPLICATION FOR DRONABINOL CAPSULES USP, 2.5 MG, 5 MG AND 10 MG

May 21 2018

BRIEF-Lannett Reports Q3 Adjusted Earnings Per Share $0.80

* LANNETT ANNOUNCES FISCAL 2018 THIRD-QUARTER FINANCIAL RESULTS

May 07 2018

BRIEF-Lannett Acquires Portfolio Of Generic Products From Endo International

* LANNETT ACQUIRES PORTFOLIO OF GENERIC PRODUCTS FROM ENDO INTERNATIONAL

May 07 2018

BRIEF-Lannett Appoints Patrick Lepore Chairman Of Board

* LEPORE WILL SUCCEED JEFFREY FARBER, WHO WILL REMAIN A MEMBER OF BOARD Source text for Eikon: Further company coverage:

Apr 30 2018

BRIEF-Lannett Company Files For Potential Mixed Shelf Offering

* LANNETT COMPANY INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING Source text: (http://bit.ly/2GblSC4) Further company coverage:

Feb 13 2018

BRIEF-Lannett Co Reports Q2 Earnings Per Share $0.37

* LANNETT ANNOUNCES FISCAL 2018 SECOND-QUARTER FINANCIAL RESULTS; REPORTS RECORD REVENUES, STRONG EARNINGS

Feb 07 2018

BRIEF-Lannett Co Voluntarily Pays Down $25 Mln Of Term Loans

* LANNETT COMPANY SAYS $25 MILLION PAY DOWN OF TERM LOANS WILL SAVE CO ABOUT $1.7 MILLION IN ANNUALIZED CASH INTEREST EXPENSE, AT CURRENT RATES Source text for Eikon: Further company coverage:

Feb 07 2018

BRIEF-Lannett Enters Into Consulting Agreement With Former CEO, Bedrosian

* LANNETT ENTERS INTO CONSULTING AGREEMENT WITH FORMER CEO, ARTHUR BEDROSIAN

Feb 01 2018

BRIEF-Lannett Names Timothy Crew To Board Of Directors

* LANNETT COMPANY INC - ‍ WITH CREW'S APPOINTMENT, TOTAL NUMBER OF DIRECTORS IS SEVEN​ Source text for Eikon: Further company coverage:

Jan 18 2018

Competitors

  Price Chg
AbbVie Inc (ABBV.N) $93.24 -0.25
Pfizer Limited (PFIZ.NS) Rs2,598.60 +2.25
Dr.Reddy's Laboratories Ltd (REDY.NS) Rs2,290.15 -46.10

Earnings vs. Estimates